[go: up one dir, main page]

AR010031A1 - ORAL VACCINE FOR ANIMALS - Google Patents

ORAL VACCINE FOR ANIMALS

Info

Publication number
AR010031A1
AR010031A1 ARP970104941A ARP970104941A AR010031A1 AR 010031 A1 AR010031 A1 AR 010031A1 AR P970104941 A ARP970104941 A AR P970104941A AR P970104941 A ARP970104941 A AR P970104941A AR 010031 A1 AR010031 A1 AR 010031A1
Authority
AR
Argentina
Prior art keywords
animals
oral vaccine
vaccine
younger
pathogen
Prior art date
Application number
ARP970104941A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR010031A1 publication Critical patent/AR010031A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Proporciona una formulacion de la vacuna y un procedimiento para la vacunacion oral de animales en edad de destete o más jovenes frente a unpatogeno en presencia de anticuerpos maternos que causan interferencia. La formulacion contiene un antígeno en una cubierta entérica.Provides a vaccine formulation and method for oral vaccination of animals of weaning age or younger against a pathogen in the presence of interfering maternal antibodies. The formulation contains an antigen in an enteric coating.

ARP970104941A 1996-10-28 1997-10-24 ORAL VACCINE FOR ANIMALS AR010031A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2880296P 1996-10-28 1996-10-28

Publications (1)

Publication Number Publication Date
AR010031A1 true AR010031A1 (en) 2000-05-17

Family

ID=21845518

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104941A AR010031A1 (en) 1996-10-28 1997-10-24 ORAL VACCINE FOR ANIMALS

Country Status (4)

Country Link
AR (1) AR010031A1 (en)
AU (1) AU4133397A (en)
WO (1) WO1998018453A1 (en)
ZA (1) ZA979592B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2382652A1 (en) * 1999-08-24 2001-03-01 Teva Pharmaceutical Industries, Ltd. A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
CA2510189A1 (en) 2002-12-19 2004-07-08 Thomas Gore Trivalent vaccine with maternal antibody transfer via the milk
PL2762163T3 (en) * 2006-12-27 2018-05-30 Zoetis Services Llc Methods of vaccine administration
CA2767673A1 (en) * 2009-07-17 2011-01-20 The Board Of Regents Of Oklahoma State University Supralingual vaccines and applicators
DK2833914T3 (en) * 2012-04-04 2019-03-11 Vaxform Llc ADMINISTRATIVE SYSTEM FOR ORAL VACCINE ADMINISTRATION
AR097762A1 (en) * 2013-09-27 2016-04-13 Intervet Int Bv DRY FORMULATIONS OF VACCINES THAT ARE STABLE AT ENVIRONMENTAL TEMPERATURE
EP3107568B1 (en) * 2014-02-20 2024-03-27 Vaxart, Inc. Formulations for small intestinal delivery
CN106460050A (en) * 2014-04-28 2017-02-22 西格马-奥尔德里奇有限责任公司 Epigenetic modification of mammalian genomes using targeted endonucleases
CN108024955A (en) 2015-06-12 2018-05-11 瓦克萨特公司 Formulations for small intestinal delivery of RSV and norovirus antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
AU576907B2 (en) * 1984-11-01 1988-09-08 American Home Products Corporation Oral vaccines comprising live recombinant adenoviruses
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
RU2045960C1 (en) * 1992-07-01 1995-10-20 Соболева Галина Леонидовна Vaccine for prevention of plague, infectious hepatitis, adenovirosis, parvoviral enteritis and canine leptospirosis

Also Published As

Publication number Publication date
WO1998018453A1 (en) 1998-05-07
ZA979592B (en) 1999-04-28
AU4133397A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
DK157087A (en) MULTIVALENT VACCINE, ESPECIALLY HERPESVIRUS VACCINE, ITS USE AND ITS CONTAINING VIRUS
NO991524L (en) vaccinations
PT90727A (en) A method for the preparation of a protein having one or more of the immunomoreactive and / or antigenic determinants of a surface antigen and efficacy of vaccines against the coccidiosis which contains it
ES2140076T3 (en) VACCINES CONTAINING A SAPONIN AND A STEROL.
IS4615A (en) Antigen Helicobacter pylori and vaccine preparations
ES2093778T3 (en) NEW ANTIBODIES AND METHODS FOR USE.
ATE264691T1 (en) NEWCASTLE DISEASE VIRUS COMBINATION VACCINE
FI953608L (en) Vaccine compositions and method for eliciting an immune response in the mucosa by systemic vaccination
BG99441A (en) Oral application of antigens
AR010031A1 (en) ORAL VACCINE FOR ANIMALS
NZ230148A (en) Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd
AU7814498A (en) Multivalent (in ovo) avian vaccine
DE69527986D1 (en) ANTIGEN MEDICINE FOR TREATMENT OR PREVENTION
NZ502144A (en) Multi-subtype FIV vaccines
ATE352315T1 (en) NEOSPORA VACCINE
AR016396A1 (en) HOMOGENEIZED PREPARED FROM NEOSPORA CELLS, VACCINE, PREPARATION PROCEDURE, VACCINATION EQUIPMENT AND ANTIBODY.
DE68914252D1 (en) Method of determining an antigen.
FI971402L (en) Method for preparing enhanced antigenic Helicobacter species and vaccines containing them
FI971403A7 (en) Method for producing enhanced antigenic enteric bacteria and vaccines containing them
AU6435596A (en) Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
BR0001559A (en) Vaccine for the prevention of colonization of campylobacter in animals, antigenic protein of campylobacter, use of an antigenic protein, vaccine for the prevention of colonization of campylobacter jejuni in chickens, use of antibodies against a flagella-free campylobacter strain, or against antigenic protein , and, process for preparing a vaccine
ATE206138T1 (en) HELICOBACTER PYLORI ANTIGEN
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
ATE369875T1 (en) ORAL VACCINATION WITH NAKED TUMOR ANTIGEN MIMOTOPES
ITMI940891A0 (en) DEVICE FOR STORAGE AND TRANSPORT OF HUMAN ORGANS, MEDICINAL SUBSTANCES, VACCINES AND SIMILAR